Skip to main content

Articles

Page 301 of 335

  1. Loss of DNA mismatch repair (MMR) in humans, mainly due to mutations in the hMLH1 gene, is linked to hereditary nonpolyposis colorectal cancer (HNPCC). Because not all MLH1 alterations result in loss of MMR funct...

    Authors: Matjaz Vogelsang, Aleksandra Comino, Neja Zupanec, Petra Hudler and Radovan Komel
    Citation: BMC Cancer 2009 9:382
  2. The transient receptor potential, subfamily V, member 6 (TRPV6) is a Ca2+ selective cation channel. Several studies have shown that TRPV6 transcripts are expressed in locally advanced prostatic adenocarcinoma, me...

    Authors: Thorsten Kessler, Ulrich Wissenbach, Rainer Grobholz and Veit Flockerzi
    Citation: BMC Cancer 2009 9:380
  3. A genome-wide association study (GWAS), which assessed multiple ethnicities, reported an association between single nucleotide polymorphisms in the 8q24 region and colorectal cancer risk. Although the associat...

    Authors: Keitaro Matsuo, Takeshi Suzuki, Hidemi Ito, Satoyo Hosono, Takakazu Kawase, Miki Watanabe, Kohei Shitara, Koji Komori, Yukihide Kanemitsu, Takashi Hirai, Yasushi Yatabe, Hideo Tanaka and Kazuo Tajima
    Citation: BMC Cancer 2009 9:379
  4. The malignant potential of serous ovarian tumors, the most common ovarian tumor subtype, varies from benign to low malignant potential (LMP) tumors to frankly invasive cancers. Given the uncertainty about the ...

    Authors: Melissa A Merritt, Peter G Parsons, Tanya R Newton, Adam C Martyn, Penelope M Webb, Adèle C Green, David J Papadimos and Glen M Boyle
    Citation: BMC Cancer 2009 9:378
  5. The glycosylphosphatidylinositol (GPI)-anchored epithelial extracellular membrane serine protease prostasin (PRSS8) is expressed abundantly in normal epithelia and essential for terminal epithelial differentia...

    Authors: Li-Mei Chen, Nicole J Verity and Karl X Chai
    Citation: BMC Cancer 2009 9:377
  6. Colorectal cancer (CRC) is one of the leading causes of malignant death worldwide. Because young age of onset is often considered a poor prognostic factor for CRC, it is important to identify the poor outcomes...

    Authors: Chun-Chao Chang, Shung-Haur Yang, Chih-Cheng Chien, Shu-Hung Chen, Shiann Pan, Chia-Long Lee, Chih-Ming Lin, Hsiao-Lun Sun, Chi-Cheng Huang, Yih-Yiing Wu, Ruey-Neng Yang and Chi-Jung Huang
    Citation: BMC Cancer 2009 9:376
  7. This study is a retrospective evaluation of the efficacy of neoadjuvant chemotherapy (NC) with a vinorelbine (V) and epirubicin (E) intravenous combination regimen and is aimed at identification of predictive ...

    Authors: Ou Huang, CanMing Chen, JiaYi Wu, ShuJie Chen, XiaoSong Chen, GuangYu Liu, Zhen Hu, JingSong Lu, Jiong Wu, ZhiMin Shao, ZhenZhou Shen and KunWei Shen
    Citation: BMC Cancer 2009 9:375
  8. MicroRNAs (MiRNAs) are short non-coding RNAs that control protein expression through various mechanisms. Their altered expression has been shown to be associated with various cancers. The aim of this study was...

    Authors: Greg M Arndt, Lesley Dossey, Lara M Cullen, Angela Lai, Riki Druker, Michael Eisbacher, Chunyan Zhang, Nham Tran, Hongtao Fan, Kathy Retzlaff, Anton Bittner and Mitch Raponi
    Citation: BMC Cancer 2009 9:374
  9. The incidence of oral and pharyngeal (including oral cavity, oropharynx and hypopharynx) carcinoma increases rapidly in Asia and South Pacific because of betel quid chewing. Thus far, large-scale epidemiologic...

    Authors: Kuan-Der Lee, Chang-Hsien Lu, Ping-Tsung Chen, Chunghuang Hubert Chan, Jen-Tsun Lin, Cih-En Huang, Chih-Cheng Chen and Min-Chi Chen
    Citation: BMC Cancer 2009 9:373
  10. Sulfasalazine, a NF-kappaB and x(c)-cystine/glutamate antiport inhibitor, has demonstrated a strong antitumoral potential in preclinical models of malignant gliomas. As it presents an excellent safety profile,...

    Authors: Pierre A Robe, Didier H Martin, Minh T Nguyen-Khac, Maria Artesi, Manuel Deprez, Adelin Albert, Sophie Vanbelle, Stephane Califice, Markus Bredel and Vincent Bours
    Citation: BMC Cancer 2009 9:372
  11. Homeodomain proteins control fundamental cellular processes in development and in cancer if deregulated. Three members of the NK-like subfamily of homeobox genes (NKLs), TLX1, TLX3 and NKX2-5, are implicated i...

    Authors: Stefan Nagel, Letizia Venturini, Grzegorz K Przybylski, Piotr Grabarczyk, Corinna Meyer, Maren Kaufmann, Karin Battmer, Christian A Schmidt, Hans G Drexler, Michaela Scherr and Roderick AF MacLeod
    Citation: BMC Cancer 2009 9:371
  12. Analysis of 23 published transcriptome studies allowed us to identify nine genes displaying frequent alterations in HNSCC (FN1, MMP1, PLAU, SPARC, IL1RN, KRT4, KRT13, MAL, and TGM3). We aimed to independently con...

    Authors: Benjamin Lallemant, Alexandre Evrard, Christophe Combescure, Heliette Chapuis, Guillaume Chambon, Caroline Raynal, Christophe Reynaud, Omar Sabra, Dominique Joubert, Frédéric Hollande, Jean-Gabriel Lallemant, Serge Lumbroso and Jean-Paul Brouillet
    Citation: BMC Cancer 2009 9:370
  13. Carcinoma of the thyroid gland is an uncommon cancer, but the most frequent malignancy of the endocrine system. Most thyroid cancers are derived from the follicular cell. Follicular carcinoma (FTC) is consider...

    Authors: Patricia J McLaughlin, Ian S Zagon, Sunny S Park, Andrea Conway, Renee N Donahue and David Goldenberg
    Citation: BMC Cancer 2009 9:369
  14. Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive markers of chemoresponse would help to individualize therapy and improve survival of ovar...

    Authors: Lovisa Österberg, Kristina Levan, Karolina Partheen, Ulla Delle, Björn Olsson, Karin Sundfeldt and György Horvath
    Citation: BMC Cancer 2009 9:368
  15. In Her2-positive advanced breast cancer, the upfront use of trastuzumab is well established. Upon progression on first-line therapy, patients may be switched to lapatinib. Others however remain candidates for ...

    Authors: Rupert Bartsch, Catharina De Vries, Ursula Pluschnig, Peter Dubsky, Zsuzsanna Bago-Horvath, Simon P Gampenrieder, Margaretha Rudas, Robert M Mader, Andrea Rottenfusser, Christoph Wiltschke, Michael Gnant, Christoph C Zielinski and Guenther G Steger
    Citation: BMC Cancer 2009 9:367
  16. Aberrant activity of tyrosine-phosphorylated proteins is commonly associated with HCC metastasis. Cell signaling events driven by these proteins are implicated in numerous processes that alter cancer cell beha...

    Authors: Haiyu Li, Zhenggang Ren, Xiaonan Kang, Lan Zhang, Xuefei Li, Yan Wang, Tongchun Xue, Yuefang Shen and Yinkun Liu
    Citation: BMC Cancer 2009 9:366
  17. Cervical cancer is the most common cancer among Indian women. The current recommendations are to treat the stage IIB, IIIA, IIIB and IVA with radical radiotherapy and weekly cisplatin based chemotherapy. Howev...

    Authors: Thangarajan Rajkumar, Neelakantan Vijayalakshmi, Kesavan Sabitha, Sundersingh Shirley, Ganesharaja Selvaluxmy, Mayil Vahanan Bose and Lavanya Nambaru
    Citation: BMC Cancer 2009 9:365
  18. Human hemangiosarcoma (HSA) tends to have a poor prognosis; its tumorigenesis has not been elucidated, as there is a dearth of HSA clinical specimens and no experimental model for HSA. However, the incidence o...

    Authors: Atsushi Kodama, Hiroki Sakai, Satoko Matsuura, Mami Murakami, Atsuko Murai, Takashi Mori, Kouji Maruo, Tohru Kimura, Toshiaki Masegi and Tokuma Yanai
    Citation: BMC Cancer 2009 9:363
  19. Prostate cancer metastasizes to regional lymph nodes and distant sites but the roles of lymphatic and hematogenous pathways in metastasis are not fully understood.

    Authors: Johanna Tuomela, Maija Valta, Jani Seppänen, Kati Tarkkonen, H Kalervo Väänänen and Pirkko Härkönen
    Citation: BMC Cancer 2009 9:362
  20. The combination therapy of interferon (IFN)-alpha and 5-fluorouracil (5-FU) improved the prognosis of the patients with hepatocellular carcinoma (HCC). To determine the molecular mechanisms of the anti-tumor a...

    Authors: Hiroshi Wada, Hiroaki Nagano, Hirofumi Yamamoto, Takehiro Noda, Masahiro Murakami, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Koji Umeshita, Yuichiro Doki and Masaki Mori
    Citation: BMC Cancer 2009 9:361
  21. BRCA1 gene-related tumours are more frequently estrogen receptor (ER) and progesterone receptor (PR) negative with a lower prevalence of human epidermal growth factor receptor 2 (HER2) overexpression or amplif...

    Authors: GianMaria Miolo, Vincenzo Canzonieri, Clelia De Giacomi, Lara Della Puppa, Riccardo Dolcetti, Davide Lombardi, Tiziana Perin, Simona Scalone, Andrea Veronesi and Alessandra Viel
    Citation: BMC Cancer 2009 9:360
  22. The DNA damage by platinum cytostatics is thought to be the main cause of their cytotoxicity. Therefore the measurement of the DNA damage induced by cis- and carboplatin should reflect the sensitivity of cance...

    Authors: Florian T Unger, Hermann A Klasen, Garri Tchartchian, Rudy L de Wilde and Irene Witte
    Citation: BMC Cancer 2009 9:359
  23. Monomeric Group IVB (Ti, Zr and Hf) metallocenes represent a new class of antitumor compounds. There is literature on the general biological activities of some organotin compounds. Unfortunately, there is litt...

    Authors: Michael R Roner, Charles E Carraher Jr, Kimberly Shahi, Yuki Ashida and Girish Barot
    Citation: BMC Cancer 2009 9:358
  24. The T antigen is a tumor-associated structure whose sialylated form (the sialyl-T antigen) involves the altered expression of sialyltransferases and has been related with worse prognosis. Since little or no in...

    Authors: Paula A Videira, Manuela Correia, Nadia Malagolini, Hélio J Crespo, Dário Ligeiro, Fernando M Calais, Helder Trindade and Fabio Dall'Olio
    Citation: BMC Cancer 2009 9:357
  25. Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary em...

    Authors: Gareth O Griffiths, Sarah Burns, Simon I Noble, Fergus R Macbeth, David Cohen and Timothy S Maughan
    Citation: BMC Cancer 2009 9:355
  26. Biomarkers that predict clinical response, tumor recurrence or patient survival are severely lacking for most cancers, particularly for oral and pharyngeal cancer. This study examines whether gene-promoter met...

    Authors: Emanuela Taioli, Camille Ragin, Xiao-hong Wang, Jiangying Chen, Scott M Langevin, Ashley R Brown, Susanne M Gollin, Seymour Garte and Robert W Sobol
    Citation: BMC Cancer 2009 9:354
  27. Deregulated miRNAs are found in cancer cells and recently in blood cells of cancer patients. Due to their inherent stability miRNAs may offer themselves for blood based tumor diagnosis. Here we addressed the q...

    Authors: Andreas Keller, Petra Leidinger, Anne Borries, Anke Wendschlag, Frank Wucherpfennig, Matthias Scheffler, Hanno Huwer, Hans-Peter Lenhof and Eckart Meese
    Citation: BMC Cancer 2009 9:353
  28. Several genetic alterations have been demonstrated to contribute to the development and progression of melanoma. In this study, we further investigated the impact of key-regulator genes in susceptibility and p...

    Authors: Milena Casula, Antonio Muggiano, Antonio Cossu, Mario Budroni, Corrado Caracò, Paolo A Ascierto, Elena Pagani, Ignazio Stanganelli, Sergio Canzanella, MariaCristina Sini, Grazia Palomba and Giuseppe Palmieri
    Citation: BMC Cancer 2009 9:352
  29. Nanocarrier-based antibody targeting is a promising modality in therapeutic and diagnostic oncology. Single-walled carbon nanotubes (SWNTs) exhibit two unique optical properties that can be exploited for these...

    Authors: Yan Xiao, Xiugong Gao, Oleh Taratula, Stephen Treado, Aaron Urbas, R David Holbrook, Richard E Cavicchi, C Thomas Avedisian, Somenath Mitra, Ronak Savla, Paul D Wagner, Sudhir Srivastava and Huixin He
    Citation: BMC Cancer 2009 9:351
  30. Imaging tools such as scanning electron microscope (SEM) and atomic force microscope (AFM) can be used to produce high-resolution topographic images of biomedical specimens and hence are well suited for imagin...

    Authors: Ruchika Kaul-Ghanekar, Sandeep Singh, Hitesh Mamgain, Archana Jalota-Badhwar, Kishore M Paknikar and Samit Chattopadhyay
    Citation: BMC Cancer 2009 9:350
  31. Despite strong evidence of an inverse association of physical activity with postmenopausal breast cancer risk, whether a certain intensity or time of life of physical activity is most effective for lowering br...

    Authors: Tricia M Peters, Steven C Moore, Gretchen L Gierach, Nicholas J Wareham, Ulf Ekelund, Albert R Hollenbeck, Arthur Schatzkin and Michael F Leitzmann
    Citation: BMC Cancer 2009 9:349
  32. Lung cancer is one of the leading causes of death in Europe and the western world. At present, diagnosis of lung cancer very often happens late in the course of the disease since inexpensive, non-invasive and ...

    Authors: Amel Bajtarevic, Clemens Ager, Martin Pienz, Martin Klieber, Konrad Schwarz, Magdalena Ligor, Tomasz Ligor, Wojciech Filipiak, Hubert Denz, Michael Fiegl, Wolfgang Hilbe, Wolfgang Weiss, Peter Lukas, Herbert Jamnig, Martin Hackl, Alfred Haidenberger…
    Citation: BMC Cancer 2009 9:348
  33. The anti-VEGF antibody bevacizumab associated with an irinotecan or oxaliplatin-based chemotherapy was proved to be superior to the chemotherapy alone in first or second line treatment of metastatic colorectal...

    Authors: Astrid Lièvre, Emmanuelle Samalin, Emmanuel Mitry, Eric Assenat, Christine Boyer-Gestin, Céline Lepère, Jean-Baptiste Bachet, Fabienne Portales, Jean-Nicolas Vaillant, Marc Ychou and Philippe Rougier
    Citation: BMC Cancer 2009 9:347
  34. Gastric cancer is the second leading cause of oncologic death worldwide. One of the most noteworthy characteristics of this tumor's epidemiology is the marked decline reported in its incidence and mortality in...

    Authors: Esther García-Esquinas, Beatriz Pérez-Gómez, Marina Pollán, Elena Boldo, Pablo Fernández-Navarro, Virginia Lope, Enrique Vidal, Gonzalo López-Abente and Nuria Aragonés
    Citation: BMC Cancer 2009 9:346
  35. There is currently no standard adjuvant therapy for patients with curatively resected extrahepatic biliary tract cancer (EHBTC). The aim of this study was to analyze the clinical features and outcomes between ...

    Authors: Kyu-Hyoung Lim, Do-Youn Oh, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Sung Whan Ha and Yung-Jue Bang
    Citation: BMC Cancer 2009 9:345
  36. MMR is responsible for the repair of base-base mismatches and insertion/deletion loops. Besides this, MMR is also associated with an anti-recombination function, suppressing homologous recombination. Losses of...

    Authors: João Conde, Susana N Silva, Ana P Azevedo, Valdemar Teixeira, Julieta Esperança Pina, José Rueff and Jorge F Gaspar
    Citation: BMC Cancer 2009 9:344
  37. Gambogic acid (GA) is a major active ingredient of gamboge, a widely used traditional Chinese medicine that has been reported to be a potent cytotoxic agent against some malignant tumors. Many studies have sho...

    Authors: Di He, Qin Xu, Ming Yan, Ping Zhang, Xiaojian Zhou, Zhiyuan Zhang, Wenhu Duan, Laiping Zhong, Dongxia Ye and Wantao Chen
    Citation: BMC Cancer 2009 9:343
  38. It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Ch...

    Authors: Yanping Lin, Wenjin Yin, Tingting Yan, Liheng Zhou, Genhong Di, Jiong Wu, Zhenzhou Shen, Zhimin Shao and Jinsong Lu
    Citation: BMC Cancer 2009 9:342
  39. In contrast to most other forms of cancer, data from some developing and developed countries show surprisingly similar survival rates for ovarian cancer. We aimed to compare ovarian cancer survival in Philippi...

    Authors: Maria Theresa M Redaniel, Adriano Laudico, Maria Rica Mirasol-Lumague, Adam Gondos, Gemma Leonora Uy, Jean Ann Toral, Doris Benavides and Hermann Brenner
    Citation: BMC Cancer 2009 9:340
  40. Thymidylate synthase (TS) and Topoisomerase I (Topo I) are significant biomarkers in colorectal cancer (CRC). We aimed to study the expression of TS and Topo I in patients with resected CRC who received adjuva...

    Authors: Ioannis Kostopoulos, Vasilios Karavasilis, Maria Karina, Mattheos Bobos, Nikolaos Xiros, George Pentheroudakis, Georgia Kafiri, Pavlos Papakostas, Eleni Vrettou and George Fountzilas
    Citation: BMC Cancer 2009 9:339
  41. Targeting angiogenesis is nowadays one of the most promising approaches for breast cancer. Bevacizumab (BEV), a VEGF-trap monoclonal antibody, was recently approved in combination with paclitaxel (PAC) for the...

    Authors: Alexandros Ardavanis, Dimitrios Doufexis, Panteleimon Kountourakis, Savvoula Malliou, Athanasios Karagiannis, Evgenia Kardara, Despina Sykoutri, Margari Charalampia and Gerasimos Rigatos
    Citation: BMC Cancer 2009 9:338
  42. HAb18G/CD147 plays pivotal roles in invasion by hepatoma cells, but the underlying mechanism remains unclear. Our previous study demonstrated that overexpression of HAb18G/CD147 promotes invasion by interactin...

    Authors: Jing-yao Dai, Ke-feng Dou, Cong-hua Wang, Pu Zhao, Wayne Bond Lau, Ling Tao, Ya-mei Wu, Juan Tang, Jian-li Jiang and Zhi-nan Chen
    Citation: BMC Cancer 2009 9:337
  43. The majority of women with ovarian cancer are diagnosed in late stages, and the mortality rate is high. The use of biomarkers as prognostic factors may improve the treatment and clinical outcome of these patie...

    Authors: Karolina Partheen, Kristina Levan, Lovisa Österberg, Ingela Claesson, Karin Sundfeldt and György Horvath
    Citation: BMC Cancer 2009 9:336
  44. Mammographic screening alone will miss a certain fraction of malignancies, as evidenced by retrospective reviews of mammograms following a subsequent screening. Mammographic breast density is a marker for incr...

    Authors: Monika Nothacker, Volker Duda, Markus Hahn, Mathias Warm, Friedrich Degenhardt, Helmut Madjar, Susanne Weinbrenner and Ute-Susann Albert
    Citation: BMC Cancer 2009 9:335
  45. In Non-small cell lung cancer (NSCLC), an overactive epidermal growth factor receptor (EGFR) pathway is a component of the malignant phenotype. Two tyrosine kinase inhibitors (TKIs) of EGFR, gefinitib and erlo...

    Authors: Ivette F Emery, Chiara Battelli, Paul L Auclair, Kathleen Carrier and Daniel M Hayes
    Citation: BMC Cancer 2009 9:333
  46. A number of studies, notably EPIC, have shown a descrease in colorectal cancer risk associated with increased fibre consumption. Whilst the underlying mechanisms are likely to be multifactorial, production of ...

    Authors: Bernard M Corfe, Elizabeth A Williams, Jonathan P Bury, Stuart A Riley, Lisa J Croucher, Daphne YL Lai and Caroline A Evans
    Citation: BMC Cancer 2009 9:332
  47. The novel breast cancer metastasis modulator gene signal-induced proliferation-associated 1 (Sipa1) underlies the breast cancer metastasis efficiency modifier locus Mtes 1 and has been shown to influence mammary ...

    Authors: Szu-Min Hsieh, Robert A Smith, Nicholas A Lintell, Kent W Hunter and Lyn R Griffiths
    Citation: BMC Cancer 2009 9:331

Featured videos

View featured videos from across the BMC-series journals